版权说明 操作指南
首页 > 成果 > 详情

CRISPR/Cas系统递送技术及其应用研究进展

认领
导出
Link by 中国知网学术期刊 Link by 万方学术期刊
反馈
分享
QQ微信 微博
成果类型:
期刊论文
论文标题(英文):
Delivery and Application Progresses of CRISPR/Cas Gene Editing System
作者:
Zhao Zi-Xuan;Li Chun-Hui;Zhou Li-Li;Zhao De-Yao;Weng Yu-Hua;...
通讯作者:
Huang Yuan-Yu
作者机构:
[Li Chun-Hui; Zhao Zi-Xuan; Huang Yuan-Yu; Zhao De-Yao; Weng Yu-Hua] Beijing Inst Technol, Inst Engn Med, Key Lab Mol Med & Biotherapy, Sch Life Sci,Adv Res Inst Multidisciplinary Sci, Beijing 100081, Peoples R China.
[Xia Xin-Hua; Zhou Li-Li; Huang Yuan-Yu] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China.
[Zhao De-Yao] Zhengzhou Univ, Dept Radiat Oncol, Affiliated Hosp 1, Zhengzhou 450000, Peoples R China.
通讯机构:
[Huang Yuan-Yu] B
[Huang Yuan-Yu] H
Beijing Inst Technol, Inst Engn Med, Key Lab Mol Med & Biotherapy, Sch Life Sci,Adv Res Inst Multidisciplinary Sci, Beijing 100081, Peoples R China.
Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Peoples R China.
语种:
中文
关键词:
基因编辑;药物递送;基因治疗;基因检测
关键词(英文):
CRISPR/Cas
期刊:
生物化学与生物物理进展
ISSN:
1000-3282
年:
2020
卷:
47
期:
4
页码:
286-299
基金类别:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31901053, 31871003]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2018JJ1019, 2019JJ50196, 2018RS3094]
机构署名:
本校为通讯机构
院系归属:
药学院
摘要:
基于CRISPR/Cas的基因编辑系统是近年来研究发展最重要的生物技术之一,其在基因编辑、核酸成像、转录调控、基因检测与疾病诊断、动物模型建立、农作物改良等领域均有十分广泛的应用.本文主要介绍了CRISPR/Cas基因编辑技术的背景与发展历程,梳理了包括纳米载体在内的各类递送技术,总结了该技术应用于疾病治疗的临床前和临床研究进展,简述了CRISPR/Cas在其他更广泛领域的应用,并就该技术面临的挑战、发展趋势和应用前景做了展望.
摘要(英文):
CRISPR/Cas-based gene editing system is one of the newly-developed and promising biotechnologies. It shows broad application prospects for gene editing, DNA and RNA imaging, regulation of gene transcription, gene detection and disease diagnosis, establishing animal disease models, and improving crop, etc. In this review, we overviewed the background and development history of CRISPR / Cas systems, discussed recently investigated delivery methods including various nanocarriers, summarize the preclinical and clinical advances of CRISPR/Cas-based therapeutics, and introduced other application are...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com